BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06754501-completion@plaintrial.com
DTSTAMP:20260926T100631Z
DTSTART;VALUE=DATE:20290701
SUMMARY:A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual
  Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGI
 T (Tiragolumab) in Cancer of Unknown Primary — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06754501
URL:https://plaintrial.com/trial/NCT06754501
END:VEVENT
END:VCALENDAR